Interventional Oncology Market Size, Trends and Forecast 2024-2032
According to FutureWise analysis the market for Interventional Oncology in 2023 was US$ 2.03 billion, and is expected to reach US$ 3.5 billion by 2031 at a CAGR of 7.02%.
Interventional oncology deals with image guidance carrying minimally invasive medical procedures for diagnosis, palliation and treatment of various cancer types. Various image-guiding techniques like fluoroscopy, ultrasound and computed tomography are implemented in interventional oncology procedures to treat and diagnose a particular site that is affected with cancer or pain. This procedure is often performed with other cancer treatments like chemotherapy, radiation therapy and surgery. Interventional oncological procedures offer multiple advantages like shorter hospital stays, quick recovery, more precise treatment and minimal side effects.
Technological advancements in interventional oncology, advantages of minimally invasive surgical procedures and increase in the funds offered by the government are some factors that have assisted in the proliferation of the market.Product-wise, the market is fragmented into embolization devices, non-radioactive embolic agents, ablation devices, support devices and guidewires. The ablation devices segment is further segmented into radiofrequency ablation devices, microwave ablation devices, cryoablation devices. The embolization devices segment is anticipated to register a remarkable CAGR during the forecast period. The process of embolization has multiple benefits which is why it is primarily preferred worldwide. It is the process of embolus lodging inside the bloodstream to block the blood supply to the tumour. The blood vessels are selectively occluded by introducing emboli using irradiation or chemical techniques.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Interventional-Oncology-Market/2336
Interventional Oncology Market Segmentation:
By Product
- Embolization Devices
- Radioembolic Agents
- Non-Radioactive Embolic Agents
- Ablation Devices
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Other Ablation Devices
- Support Devices
- Microcatheters
- Guidewires
By Procedure
- Thermal Tumour Ablation
- Non-thermal Tumour Ablation
- Transcatheter Arterial Chemoembolization
- Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
- Transcatheter Arterial Embolization/Bland Embolization
By Cancer Type
- Liver Cancer
- Lung Cancer
- Bone Cancer
- Kidney Cancer
- Other Cancers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Interventional Oncology Market:
- Medtronic
- Boston Scientific
- BTG Plc.
- Terumo
- Merit Medical
- Sirtex
- Ethicon
- Cook Medical
- Teleflex
- HealthTronics
- MedWaves Medical
- IceCure Medical
- Interface Biomaterial BV
- Mermaid Medicals
- ABK Biomedical
- Guerbet
- Endo Shape
- Instylla
- Shape Memory Medical
- Monteris Medical
- Trisalus Lifesciences
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=2336%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Interventional Oncology Market By Product, By Procedure, By Cancer Type and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian